2022
The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial
Cassidy R, Tidey J, Jackson K, Cioe P, Murphy S, Krishnan-Sarin S, Hatsukami D, Colby S. The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial. Nicotine & Tobacco Research 2022, 25: 918-927. PMID: 36482794, PMCID: PMC10077938, DOI: 10.1093/ntr/ntac279.Peer-Reviewed Original ResearchConceptsVLNC cigarettesAdolescent daily smokersNNC cigarettesCigarette smokingDaily smokersWeek 3First clinical trialSources of nicotineNicotine contentLow nicotine contentAdolescent cigarette smokingRespiratory symptomsSecondary outcomesPrimary outcomeControlled TrialsNicotine exposureTotal cigarettesIncomplete adherenceNicotine cigarettesClinical trialsAdolescent smokersTwo-armUS FoodControl groupDrug Administration
2009
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
Rothberg BE, Bracken MB, Rimm DL. Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2009, 101: 452-474. PMID: 19318635, PMCID: PMC2720709, DOI: 10.1093/jnci/djp038.Peer-Reviewed Original ResearchConceptsCohort studyCutaneous melanomaMelanoma cell adhesion moleculeSystematic reviewEarly-stage cutaneous melanomaPotential prognostic valueMatrix metalloproteinase-2Cell nuclear antigenREMARK criteriaAdjuvant therapyMultivariable analysisREMARK guidelinesRisk stratificationPrognostic valueSurvival outcomesIncomplete adherenceMelanoma outcomesClinical managementImmunohistochemical expressionCell adhesion moleculeInclusion criteriaKi-67Tissue biomarkersClinical practiceMetalloproteinase-2
2001
Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states
Wilson T, Ickovics J, Fernandez M, Koenig L, Walter E, Project F. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. American Journal Of Obstetrics And Gynecology 2001, 184: 1235-1240. PMID: 11349194, DOI: 10.1067/mob.2001.114032.Peer-Reviewed Original ResearchConceptsPregnant womenHuman immunodeficiency virus-infected pregnant womenHuman immunodeficiency virus (HIV) infectionPrenatal illicit drug useImmunodeficiency virus infectionPrenatal care settingsIllicit drug useIllicit drug usersPrenatal zidovudineZidovudine dosesZidovudine useZidovudine therapyWeeks' gestationPrenatal vitaminsIncomplete adherencePrenatal clinicsRegimen adherenceVirus infectionCare settingsPsychosocial factorsDrug usersDrug useMultivariate analysisWomenAdherence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply